Compound Detail
CHEMBL1734
SOLIFENACIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1734 |
| Name | SOLIFENACIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | FBOUYBDGKBSUES-VXKWHMMOSA-N |
| Therapeutic | ✓ Yes |
15
Targets
20
Activities
3
Assay Types
15
PK Parameters
20
Publications
5
Known Names
5
Indications
Molecular Properties
362.5
MW (Da)
3.86
ALogP
3
HBA
0
HBD
32.8
PSA (Ų)
0.81
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2004 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Polyuria Urinary Incontinence Prostatic Hyperplasia Urinary Bladder, Overactive Urinary Incontinence, Urge
ATC Classification
G04BD08
solifenacin
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
IC50 9 meas. best 7.62
Ki 8 meas. best 8.0
EC50 3 meas. best 7.62
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.02 | - | Homo sapiens |
| Fu | 0.02 | - | Homo sapiens |
| Fu | 0.017 | - | Homo sapiens |
| Fu | 0.016 | - | Macaca fascicularis |
| Fu | 0.018 | - | Canis lupus familiaris |
| Fu | 0.014 | - | Cavia porcellus |
| Fu | 0.016 | - | Mus musculus |
| Fu | 0.015 | - | Rattus norvegicus |
| Fu | 0.019 | - | Rattus norvegicus |
| MRT | 65.0 | hr | Homo sapiens |
| T1/2 | 52.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 16220976 | 10.1021/jm050099q | Rattus norvegicus | 5 |
| 21474681 | 10.1124/dmd.111.038778 | Brain | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 20070106 | 10.1021/jm901371v | Plasma | 1 |
| 18426954 | 10.1124/dmd.108.020479 | NON-PROTEIN TARGET | 1 |
| 16220976 | 10.1021/jm050099q | Muscarinic acetylcholine receptor M1 | 1 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-dependent L-type calcium channel subunit alpha-1C | 1 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Sodium channel protein type 5 subunit alpha | 1 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) | 1 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | A-type voltage-gated potassium channel KCND3 | 1 |
| 23812503 | 10.1038/srep02100 | Voltage-gated L-type calcium channel | 1 |
| 21474681 | 10.1124/dmd.111.038778 | NON-PROTEIN TARGET | 1 |
| 16220976 | 10.1021/jm050099q | Muscarinic receptor M2 and M3 | 1 |
| 36368496 | 10.1016/j.bmcl.2022.129048 | Muscarinic acetylcholine receptor M3 | 1 |
| 16220976 | 10.1021/jm050099q | Muscarinic acetylcholine receptor M3 | 1 |
Data from ChEMBL 36 via Core Engine